A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Pfizer
Pfizer
Addario Lung Cancer Medical Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fudan University
Institut Bergonié
Pfizer
Boehringer Ingelheim
University of Liege
Boehringer Ingelheim
Abramson Cancer Center at Penn Medicine
University of Minnesota
Pfizer
Boehringer Ingelheim
Hackensack Meridian Health
Pfizer
Fred Hutchinson Cancer Center
Pfizer
Boehringer Ingelheim
Boehringer Ingelheim
Pfizer
AIDS Malignancy Consortium
Lexington Medical Inc.
Medtronic - MITG
Boehringer Ingelheim
Boehringer Ingelheim
MSD Belgium BVBA
University of Chicago
Wissenschaftliches Institut Bethanien e.V
Boehringer Ingelheim
Boehringer Ingelheim
Genomic Health®, Inc.
Boehringer Ingelheim
Baptist Memorial Health Care Corporation
University of Liege
Boehringer Ingelheim
Pfizer
Chugai Pharma France
Pfizer
Fresh Medical Laboratories
University of Maryland, Baltimore
Boehringer Ingelheim
Pfizer
Boehringer Ingelheim
Instituto Nacional de Cancerologia de Mexico
Boehringer Ingelheim
Tata Memorial Hospital
First People's Hospital of Hangzhou
Hoffmann-La Roche
GlaxoSmithKline
The Cleveland Clinic